As cold and flu season grips the country, many are reaching for over-the-counter remedies to soothe their symptoms. But beware—one popular cough syrup has just been deemed a health risk by the Chief Pharmaceutical Inspectorate and is being pulled from shelves nationwide.
If you have Pulmopect syrup in your medicine cabinet, stop using it immediately and dispose of it properly. This defective product, used to treat dry cough in children over 2 years old and adults, has already reached thousands of homes across Poland.
What’s the Issue?
The recall affects Pulmopect (Levodropropizinum) syrup, 30 mg/5 ml, sold in 100 ml and 200 ml bottles. The defect? A gelatinous substance in the syrup that doesn’t dissolve when shaken, raising serious concerns about its safety.
The affected batches include series numbers: 23371001A, 23371002A, 23371003A, and more. The product is manufactured by Adamed Pharma S.A., a well-known name in Polish pharmaceuticals.
How Widespread Is It?
Over the last month alone, 16,000 bottles of the defective syrup were sold. Warsaw saw the highest distribution, with 550 bottles purchased, followed by Szczecin, Gdańsk, Wrocław, and Gniezno. Smaller cities like Lublin, Rybnik, and Poznań also reported significant sales.
If you’ve recently bought Pulmopect syrup, check the batch number immediately.
Protect Your Health
Authorities urge everyone to take this warning seriously. Keep your household safe by checking your first aid supplies and spreading the word to friends and family.When it comes to your health, there’s no room for compromise—dispose of Pulmopect and consult a healthcare professional if you’ve already used it.
